Advice

Following a resubmission

lidocaine 5% medicated plaster (Versatis®) is accepted for restricted use within NHS Scotland for the treatment of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia).

There are only limited comparative data available for lidocaine plasters, the comparative clinical effectiveness remains unclear. It is restricted to use in patients who are intolerant of first-line systemic therapies for post-herpetic neuralgia or where these therapies have been ineffective.

Download detailed advice57KB (PDF)

Download

Medicine details

Medicine name:
lidocaine 5% medicated plaster (Versatis)
SMC ID:
334/06
Indication:
Treatment of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN)
Pharmaceutical company
Grünenthal Ltd
BNF chapter
Anaesthesia
Submission type
Resubmission
Status
Restricted
Date advice published
11 August 2008